{"collection_id":"eay131","collection_name":"EAY131","cancer_types":"Adenocarcinoma, Adrenocortical Carcinoma, Anal Cancer, Anal Squamous Cell Carcinoma, Astrocytoma, Bladder Cancer, Brain Cancer, Breast Cancer, Cervical Cancer, Cervical Squamous Cell Carcinoma, Cholangiocarcinoma, Colorectal Cancer, Esophageal Carcinoma, Ewing sarcoma - Peripheral PNET, Gastrointestinal Stromal Tumor, Glioblastoma Multiforme, Glioma, Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma, Hodgkin Lymphoma, Kidney Cancer, Leukemia, Liver Cancer, Lung Adenocarcinoma, Lung Cancer, Lung Squamous Cell Carcinoma, Lymphoma, Melanoma, Mesothelioma, Multiple Myeloma, Nasopharyngeal Cancer, Neuroendocrine cancer (NOS), Non-small Cell Lung Cancer, Osteosarcoma, Ovarian Cancer, Pancreatic Cancer, Prostate Cancer, Sarcomas, Skin Cancer, Small Cell Lung Cancer, Squamous Cell Carcinoma, Thyroid Cancer, Thymoma, Urothelial - bladder cancer (NOS), Uveal Melanoma, Wilms Tumor","tumor_locations":"Various","species":"Human","subjects":2813,"supporting_data":"Clinical","description":"This collection contains imaging and clinical data for \"unmatched\" patients who didn't meet the\ncriteria for the genetic sub-studies in the \"Targeted Therapy Directed by Genetic Testing in\nTreating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The\nMATCH Screening Trial).\" This trial was sponsored by the National Cancer Institute and performed\nby the ECOG-ACRIN Cancer Research Group under study numbers NCT02465060 and EAY131. The Study\nChair was Keith T Flaherty, MD.\nPlease see the EAY131 (https://doi.org/10.7937/c5ke-yx42) wiki page to learn more about the\nimages and to obtain any supporting metadata for this collection.","patients":2813,"studies":3124,"series":30293,"instances":1451464,"size_TB":0.797,"modalities":["CT","MR","NM","PT","RTSTRUCT","SEG","XA"],"licenses":[{"license_short_name":"CC BY 4.0","series":30293,"size_TB":0.797}]}